Used primarily in the development of targeted cancer therapies, this compound serves as a linker in antibody-drug conjugates (ADCs). Its structure allows for the attachment of cytotoxic agents to antibodies, enabling precise delivery to cancer cells while minimizing damage to healthy tissues. Additionally, it is employed in research for creating prodrugs, where its properties help improve solubility and bioavailability of therapeutic agents. The compound also finds application in the study of immunomodulatory drugs, particularly in enhancing the efficacy of treatments for conditions like multiple myeloma and leprosy. Its role in facilitating controlled drug release and targeted delivery makes it valuable in advanced pharmaceutical formulations.